Medical Laboratory Observer
Founded in 1969, Medical Laboratory Observer (MLO) serves as a valuable resource for clinical laboratory professionals. It offers access to peer-reviewed articles, continuing education (CE) opportunities, management advice for labs, and the latest advancements in molecular diagnostics. Additionally, MLO covers topics like infection control, oncology, pathology practices, regulatory changes, industry developments, and reviews of new products.
Outlet metrics
Global
#1190855
United States
#639411
Health/Health
#10227
Articles
-
6 days ago |
mlo-online.com | Erin Brady
The University of Michigan conducted three studies hoping to combat primary care doctor burnout. According to a release, digital patient portal messaging is causing burnout. The studies found that:·Female doctors reported more “negative or demeaning” messages from patients. ·More female doctors attributed their burnout to patient messages.
-
6 days ago |
mlo-online.com | Erin Brady
The World Health Organization (WHO) released guidelines for defending infants from respiratory syncytial virus (RSV), according to an announcement. The article, titled WHO position paper on immunization to protect infants against respiratory syncytial virus disease, details WHO’s suggestions for RSV vaccines for mothers and infants.
-
6 days ago |
mlo-online.com | Erin Brady
The World Health Organization (WHO) released an information sheet regarding flavored nicotine products. They say flavors like bubble gum and cotton candy are the reason why teens are getting addicted.
-
1 week ago |
mlo-online.com | Erin Brady
BayCare Health System and the U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR) settled for $800,000 over alleged HIPAA violations, according to an announcement. OCR received a complaint in 2018 that an unauthorized individual had access to a patient’s electronic protected health information (ePHI), and began an analysis.
-
1 week ago |
mlo-online.com | Erin Brady
Cancer patients may have a new option for managing pain, according to the National Institutes of Health (NIH). The non-addictive treatment is “plant-derived molecule resiniferatoxin (RTX).” A group of NIH researchers found the therapy to be “a safe and effective agent for pain control in patients with intractable cancer pain” after a clinical trial.
Medical Laboratory Observer journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
https://www.mlo-online.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →